Five vendors shipped AI agent governance products in a 13-day window:
- Oct 13, 2026 — Workday’s Trusted Agent Platform went headless, letting customers build and run AI agents across HR and finance with their own tools and models. (Workday newsroom, investor relations copy)
- Oct 13, 2026 — DXC Technology and LangChain announced a partnership to scale “governed AI agent harnesses” for mission-critical IT operations. (PR Newswire, independent context via Unite.AI)
- Oct 14, 2026 — NeuBird launched general availability of its Agentic Reliability Center (ARC), aimed at governing every AI agent that touches production systems. (BusinessWire)
- Oct 15, 2026 — ServiceNow announced “AI Passport,” a cryptographically signed runtime credential for first- and third-party agents and MCP servers, plus shadow-AI discovery tools across its platform. (Futurum Group analysis, independent technical writeup)
- Oct 15, 2026 — Proofpoint announced a $6.3 billion acquisition of Varonis, explicitly framed around agent data security — the largest cybersecurity acquisition of 2026 so far. (Forkast analysis, BankInfoSecurity)
Forkast tied all five together on Oct 17 in a piece arguing none of them actually solve the measurement problem — i.e., none demonstrate that the control works in practice, only that it exists. (Forkast, Oct 17)
The core argument
Credentials, dashboards, and runtime passports all answer “does a control exist?” None of the five answer “does the control actually stop the thing it claims to stop, under adversarial conditions, at the rate the vendor implies?” That’s a measurement gap, not a maturity signal. A cryptographic AI Passport proves an agent has a credential — it doesn’t prove the credential’s scope was correctly set, or that nobody over-provisioned it during a crunch sprint. An “Agentic Reliability Center” proves telemetry is flowing — it doesn’t prove anyone is acting on the telemetry before an agent does damage.
For a 50–500 employee org evaluating any of these (or next month’s five), the practical takeaway isn’t “ignore this category” — enterprise-grade agent governance is clearly becoming a real product line, not vaporware. The takeaway is: a glossy launch announcement is marketing, not evidence.
Four questions to ask before buying any agent-governance product
- Show me a failed attack, not a passing test. Ask the vendor to demonstrate their control actively stopping a live attempt — a scope violation, a prompt injection, an over-broad data pull — in front of you. A slide claiming “99% detection” is not the same as watching it work.
- Who reviews the exceptions? Every governance tool has an override path for when the agent needs more access than its default policy allows. Ask who approves that override, how often it’s used, and whether those approvals get audited later — or just granted and forgotten.
- What happens when the tool itself is wrong? A credential system or reliability center can have false positives (blocking legitimate agent work) and false negatives (missing a real violation). Ask for their false-negative rate in a real deployment, not a lab benchmark, and what the fallback looks like when the tool misses something.
- Does this integrate with what I already have, or is it another silo? Five unrelated vendors each built their own version of “prove the agent is who it says it is.” If you adopt two of these products, do their credentials, logs, and policies talk to each other — or do you now have two governance dashboards that don’t share a definition of “authorized”?
From the field
I haven’t run a full vendor evaluation for one of these governance platforms myself, so I won’t pretend otherwise. But the standard I’d hold any vendor to is simple: show, don’t tell. I want a live demo against a real scenario, not a slide deck. I want to talk to a reference customer who has actually run the tool in production long enough to hit its failure cases, not just its happy path. And if a vendor is confident in their control, they should be comfortable putting it in front of a trial period before I commit budget. A company that resists any of those three — live demo, real references, a trial — is telling me something, even if the sales pitch sounds great.
News disclaimer: This article discusses recent vendor product announcements. Claims attributed to vendors are their own; independent analysis is sourced and linked throughout.